AAAAAA

   
Results: 1-11 |
Results: 11

Authors: BAN TA GASZNER P AGUGLIA E BATISTA R CASTILLO A LIPCSEY A MACHER JP TORRESRUIZ A VERGARA L
Citation: Ta. Ban et al., CLINICAL EFFICACY OF REBOXETINE - A COMPARATIVE-STUDY WITH DESIPRAMINE, WITH METHODOLOGICAL CONSIDERATIONS, Human psychopharmacology, 13, 1998, pp. 29-39

Authors: BRUNELLO N RAGAGNI G SZABADI E BRADSHAW CM BOSTON PF LANGELY RW HINDMARCH I BAN TA GASZNER P AGUGLIA E BATISTA R COSTILLO A LIPSCEY A MACHER JP RUIZ AT VERGARA L
Citation: N. Brunello et al., THE ROLE OF REBOXETINE, A SELECTIVE NORADRENALINE REUPTAKE INHIBITOR,IN THE TREATMENT OF DEPRESSION - PROCEEDINGS OF A SATELLITE SYMPOSIUMTO THE EUROPEAN CONGRESS OF THE WORLD-PSYCHIATRIC-ASSOCIATION, GENEVA, 1997 - DISCUSSION, Human psychopharmacology, 13, 1998, pp. 42-44

Authors: LEHMANN HE BAN TA
Citation: He. Lehmann et Ta. Ban, THE DISCOVERERS OF THE THERAPEUTIC EFFECT OF CHLORPROMAZINE IN PSYCHIATRY - QUI-ETAIENT-LES-VRAIS-PREMIERS-PRATICIENS - AUTHORS RESPOND, Canadian journal of psychiatry, 43(4), 1998, pp. 424-424

Authors: LEHMANN HE BAN TA
Citation: He. Lehmann et Ta. Ban, THE HISTORY OF THE PSYCHOPHARMACOLOGY OF SCHIZOPHRENIA, Canadian journal of psychiatry, 42(2), 1997, pp. 152-162

Authors: PARNETTI L BAN TA SENIN T
Citation: L. Parnetti et al., GLYCOSAMINOGLYCAN POLYSULFATE IN PRIMARY DEGENERATIVE DEMENTIA - PILOT-STUDY OF BIOLOGIC AND CLINICAL EFFECTS, Neuropsychobiology, 31(2), 1995, pp. 76-80

Authors: BAN TA
Citation: Ta. Ban, PSYCHOPHARMACOLOGY AND SUCCESSFUL CEREBRAL AGING, Progress in neuro-psychopharmacology & biological psychiatry, 19(1), 1995, pp. 1-9

Authors: UHLENHUTH EH BALTER MB BAN TA YANG K
Citation: Eh. Uhlenhuth et al., INTERNATIONAL STUDY OF EXPERT JUDGMENT ON THERAPEUTIC USE OF BENZODIAZEPINES AND OTHER PSYCHOTHERAPEUTIC MEDICATIONS .2. PHARMACOTHERAPY OFANXIETY DISORDERS, Journal of affective disorders, 35(4), 1995, pp. 153-162

Authors: UHLENHUTH EH BALTER MB BAN TA YANG K
Citation: Eh. Uhlenhuth et al., INTERNATIONAL STUDY OF EXPERT JUDGMENT ON THERAPEUTIC USE OF BENZODIAZEPINES AND OTHER PSYCHOTHERAPEUTIC MEDICATIONS .3. CLINICAL-FEATURES AFFECTING EXPERTS THERAPEUTIC RECOMMENDATIONS IN ANXIETY DISORDERS, Psychopharmacology bulletin, 31(2), 1995, pp. 289-296

Authors: FURUKAWA T TAKAHASHI K KITAMURA T OKAWA M MIYAOKA H HIRAI T UEDA H SAKAMOTO K MIKI K FUJITA K ANRAKU K YOKOUCHI T MIZUKAWA R HIRANO M IIDA S YOSHIMURA R KAMEI K TSUBOI K YONEDA H BAN TA
Citation: T. Furukawa et al., THE COMPREHENSIVE ASSESSMENT LIST FOR AFFECTIVE-DISORDERS (COALA) - APOLYDIAGNOSTIC, COMPREHENSIVE, AND SERIAL SEMISTRUCTURED INTERVIEW SYSTEM FOR AFFECTIVE AND RELATED DISORDERS, Acta psychiatrica Scandinavica, 91, 1995, pp. 1

Authors: BALTER MB BAN TA UHLENHUTH EH
Citation: Mb. Balter et al., INTERNATIONAL STUDY OF EXPERT JUDGMENT ON THERAPEUTIC USE OF BENZODIAZEPINES AND OTHER PSYCHOTHERAPEUTIC MEDICATIONS .1. CURRENT CONCERNS, Human psychopharmacology, 8(4), 1993, pp. 253-261

Authors: CONTI L CASSANO G BAN TA FJETLAND OK GROSSI D LAZZERINI F MODAFFERI A MOREY LC PLACIDI GF POSTIGLIONE A RE F SANTINI V
Citation: L. Conti et al., TREATMENT OF PRIMARY DEGENERATIVE DEMENTIA AND MULTIINFARCT DEMENTIA WITH GLYCOSAMINOGLYCAN POLYSULFATE - A COMPARISON OF 2 DIAGNOSES AND 2DOSES, Current therapeutic research, 54(1), 1993, pp. 44-64
Risultati: 1-11 |